Mycoplasma knocks down ADG and secondary cull markets
In an industry where health challenges can determine the difference between profitability and loss, why not eliminate a challenge when you can? Dr. Amy Maschhoff discusses practical strategies used, lessons learned and benefits measured after eliminating M. Hyo from The Maschhoffs LLC System.
October 4, 2023
In an industry where health challenges can determine the difference between profitability and loss, why not eliminate a challenge when you can?
Host Sarah Muirhead sits down with Dr. Amy Maschhoff from The Maschhoffs LLC System to discuss practical strategies, lessons and benefits seen from eliminating M. Hyo, a common cause of coinfections.
They discuss:
Costs of mycoplasma to a system
Lessons learned from eliminating the disease
Benefits to the production system as a whole
Backup plans if the original elimination plan doesn’t work
Future opportunities
Dr. Amy Maschhoff is the director of health and animal care for The Maschhoffs, LLC. She earned her veterinary degree from the University of Illinois Urbana-Champaign and began her career as herd veterinarian for The Maschhoffs. Now she serves in a more central role for the Maschhoff system.
This podcast is one of a four-part series on controlling costs with herd health brought to you by Pharmgate Animal Health. Check out the other three episodes for discussions on PRRS, Lawsonia and porcine sapovirus. Call your Pharmgate representative or visit pharmgate.com to learn about their broad portfolio of options to support your protocols.
You May Also Like